Results 1 to 10 of about 28,240 (212)
Journal of Pain and Symptom Management, 2017 Therapeutic Reviews aim to provide essential independent information for health professionals about drugs used in palliative and hospice care. Additional content is available on www.palliativedrugs.com. Country-specific books (Hospice and Palliative Care Formulary USA, and Palliative Care Formulary, British and Canadian editions) are also available and
Laura Carone +5 more
openaire +2 more sources
Spironolactone-induced gynecomastia [PDF]
Canadian Medical Association Journal, 2007 What's your call? ![Figure][1] Figure. Bilateral breast tenderness and enlargement in a 76-year-old man with congestive heart failure. This patient reported bilateral increasing breast size and tenderness. Examination of his breasts revealed gynecomastia (Tanner stage III).
Alex Suter, Florim Cuculi, Paul Erne
openaire +3 more sources
A comparison between spironolactone and spironolactone plus finasteride in the treatment of hirsutism [PDF]
European Journal of Endocrinology, 2004 OBJECTIVE: To compare the clinical efficacy and safety of the combination of spironolactone (100 mg/day) plus finasteride (5 mg/day) and spironolactone (100 mg/day) alone in the treatment of hirsutism. PATIENTS AND MEASUREMENTS: Sixty-five hirsute women were randomly assigned to one of these two treatment groups.
Sahin, Yılmaz +4 more
openaire +4 more sources
Effect of Spironolactone on Diabetic Nephropathy Compared to the Combination of Spironolactone and Losartan [PDF]
Nephro-Urology Monthly, 2014 Diabetic nephropathy is the most important cause of end stage renal disease (ESRD). Aldosterone is involved in renal damage through induction of fibrosis, inflammation and necrosis in the kidney tissue. Previous studies have demonstrated that the combination of angiotensin receptor blocker (ARB) and spironolactone (an anti-aldosterone drug) are ...
Zahra Kashi +4 more
openaire +3 more sources
Spironolactone and diabetic ketoacidosis [PDF]
Postgraduate Medical Journal, 1981 Summary The authors describe a diabetic patient on spironolactone who, following a minor surgical procedure, developed ketoacidosis and life-threatening hyperkalaemia.
A. Lever +3 more
openaire +3 more sources
Spironolactone as an Adjuvant to the Treatment of Congestive Cardiac Failure [PDF]
, 1964 David W. Evans +2 more
openalex +1 more source
Blocking by spironolactone (SC 9420) of the action of aldosterone upon the intestinal transport of potassium, sodium, and water. [PDF]
, 1966 R. G. Elmslie +2 more
openalex +1 more source
Cross reactivity of digitoxin and spironolactone in two radioimmunoassays for serum digoxin. [PDF]
, 1978 H Müller, H Bräuer, B Resch
openalex +1 more source
Effect of spironolactone on stool electrolyte losses during human cholera [PDF]
, 1972 Richard L. Guerrant +2 more
openalex +1 more source